Expressed on a number of T-cell subsets (including Tregs), because of its expression by tumor-infiltrating lymphocytes49 often in association with exhaustion markers, LAG-3 has become an important potential target for immunotherapy50. The gene discussed is LAG3; the disease is neoplasm.